Newsroom | 26064 results

MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of up to 94,050 shares of common stock. Awards were made to nine new employees of the Company. The awards were granted as an inducement material to the new employees becoming employees of the Company in accordance with Nasdaq Listing Rule 5635(c)(4) and have been approved by the Company’s Compensation Committe...

HYOGO, Japan--(BUSINESS WIRE)--JCR announced that the Company presented preclinical data from its novel adeno-associated virus (AAV) gene therapy research programs at ASGCT 2025....

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) announced today the early tender results for its tender offers to purchase for cash certain of its outstanding series of Notes. IFF also announced it has increased the previously announced Pool 1 Maximum Amount (as defined below) from $1,000,000,000 to $1,100,000,000 (the “Amended Pool 1 Maximum Amount”), the Pool 2 Maximum Amount (as defined below) from $800,000,000 to $900,000,000 (the “Amended Pool 2 Maximum Amount”, and together with the Amended Po...

BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first patient has been dosed in the Phase II/III clinical trial of its novel TYK2 inhibitor, Soficitinib (ICP-332), for the treatment of patients with non-segmental vitiligo in China. Soficitinib is a potent and selective TYK2 inhibitor that is being developed for the treatment of various T-cell related au...

ORLANDO, Fla.--(BUSINESS WIRE)--Fonon Technologies, a provider of state-of-the-art laser technologies for material processing and defense infrastructures, today showcased the groundbreaking applications of its handheld DefenseTech laser cleaning systems, heralding a paradigm shift in naval asset protection and operational longevity. The cutting edge DefenseTech line of handheld and automated laser cleaning systems offers a versatile, sustainable, non-abrasive, and highly efficient range of prod...

DOUGLAS, Isle of Man--(BUSINESS WIRE)--Lifezone Metals Limited (NYSE: LZM) (the “Company” or “Lifezone Metals”) announces the results of voting by shareholders at its 2025 Annual General Meeting (the “AGM”) held today in the Isle of Man. The ordinary resolutions below were passed by shareholders, with voting results as follows: Ordinary Resolutions For % For Against % Against Abstained % Abstained To receive the Company’s accounts for the financial year ended December 31, 2024 57,260,294 99.98%...

FARMINGTON, Conn.--(BUSINESS WIRE)--Horizon Technology Finance Corporation (NASDAQ: HRZN) (“Horizon” or “HRZN”) (the “Company”), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital and private equity backed and publicly traded companies in the technology, life science, healthcare information and services, and sustainability industries, announced today that, as part of the Company’s succession planning, Rob...

EMERYVILLE, Californie--(BUSINESS WIRE)--Prolific Machines, leader des technologies photomoléculaires, a annoncé aujourd’hui la nomination de Julien Meissonnier, ancien directeur scientifique de Catalent, au poste d’administrateur indépendant au sein de son conseil d’administration. Fort de plus de 26 ans d’expertise dans les services pharmaceutiques et les sciences de la vie, M. Meissonnier mettra ses connaissances au service des innovateurs du secteur afin de leur permettre de tirer pleinemen...

MANHASSET, N.Y.--(BUSINESS WIRE)--The Feinstein Institutes for Medical Research has selected Jeffery W. Kelly, PhD, from Scripps Research, to receive the 12th annual Ross Prize in Molecular Medicine. Dr. Kelly is recognized for his groundbreaking research into protein folding, misfolding and aggregation, along with their impact on developing novel therapeutic strategies for amyloid diseases. The prize will be presented on June 4, in conjunction with the New York Academy of Sciences (NYAS), at T...

FARGO, N.D. & CORALVILLE, Iowa--(BUSINESS WIRE)--N of 1 therapy uniquely developed for infant with life-threatening rare metabolic disorder in six months by Aldevron and Integrated DNA Technologies....